Pharmaceutical Biotechnology (Track)



CYCLO-(HIS, LEU): A NEW MICROBIAL DIKETOPIPERAZINE FROM A TERRESTRIAL BACILLUS SUBTILIS STRAIN B38

Salem Elkahoui, Hamdi Abdel Rahim, Olfa Tabbene, Mohamed Shaabanb, Ferid Limam and Hartmut Laatsch


Laboratory of Bioactive Substances, Centre of Biotechnology of Borj-Cedria, Tunisia

Abstract:

Diketopiperazines are the smallest cyclic peptides. Some of their most important biological activities are related to the inhibition of plasminogen activator inhibitor-1 and the alteration of cardiovascular and blood-clotting functions. They also were claimed to have activities as antitumour, antiviral, antifungal, antibacterial and antihyperglycaemic agents, and to have affinities for calcium channels and opioid. In continuation of our search for bioactive secondary metabolites from terrestrial Bacillus spp., a new microbial diketopiperazine, cis-cyclo-(His,Leu) was isolated from the ethyl acetate extract of a strain B. subtilis B38, together with cis-cyclo-( Phe,Phe), tryptophane, cis-cyclo-(Leu,Tyr), cis-cyclo-(Trp,Tyr) and macrolactin A. The chemical structures of the isolated compounds were identified by comparison of their 1D, 2D NMR and HRESIMS data with authentic spectra and literatures. To the best of our knowledge, this is the first time that cyclo-(His, Leu) has been isolated from natural products.

Keywords: Bacillus spp., antibacterial activity, cis-cyclo-(His,Leu).